Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 9, 2018 | CStone Pharmaceuticals | $259.2M Series B | GIC | 3W Partners, 6 Dimensions Capital, ARCH Venture Partners, Boyu Capital, CPE, Hillhouse Capital, Hongshan Capital Group (Sequoia Capital China), King Star Capital, Taikang, Terra Magnum Capital Partners, WuXi Healthcare Ventures, Yunfeng Capital |
| Mar 8, 2018 | JW Therapeutics | $90.0M Series A | Hongshan Capital Group (Sequoia Capital China), Temasek, YuanMing Capital | Juno Therapeutics, WuXi AppTec, Yipu Capital |
| Mar 1, 2018 | Hua Medicine | $120.0M Series D | — | ARCH Venture Partners, Flagship Ventures, F-Prime Capital Partners, Meritech Capital Partners, Venrock, 6 Dimensions Capital, Ally Bridge Group, Blue Pool Capital, Eight Roads Ventures, F-Prime Capital, GIC, Harvest Investments, Adrian Cheng, Mirae Asset, Ping An Ventures, WuXi AppTec |